Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry.

RECOMMENDED

Asthma

Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry

★ 1 Recommended by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

J Asthma Allergy

Puggioni F, Brussino L, Canonica GW, Blasi F, Paggiaro P, Caminati M, Latorre M, Heffler E, Senna G, Severe Asthma Network in Italy (SANI) group.

doi: 10.2147/JAA.S274245

RECOMMENDED

Asthma

Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era

★ 2 Recommended by Dr Martin Frey, Faculty Member

Thorax

Jackson DJ, Busby J, Pfeffer PE, Menzies-Gow A, Brown T, Gore R, Doherty M, Mansur AH, Message S, Niven R, Patel M, Heaney LG, UK Severe Asthma Registry.

doi: 10.1136/thoraxjnl-2020-215168

RECOMMENDED

Asthma

A Charter to Improve Patient Care in Severe Asthma

doi: 10.1007/s12325-018-0777-y.

RECOMMENDED

Asthma

Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature

Eur Respir J.

Volmer T, Effenberger T, Trautner C, Buhl R

doi: 10.1183/13993003.

COMMENTED

Effects of Systemic Corticosteroids on Blood Eosinophil Counts in Asthma: Real-World Data

J Asthma.

Ortega H, Llanos JP, Lafeuille MH, Duh MS, Germain G, Lejeune D, Sama S, Bell C, Hahn B

doi: 10.1080/

RECOMMENDED

Asthma

Differentiation of adult severe asthma from difficult-to-treat asthma - Outcomes of a systematic assessment protocol

Respir Med.

von Bülow A, Backer V, Bodtger U, Søes-Petersen NU, Vest S, Steffensen I, Porsbjerg C

doi: 10.1016/j.rmed.2018.10.020.

RECOMMENDED

Asthma

Characterization of severe asthma worldwide: data from the International Severe Asthma Registry (ISAR)

★ 3 Recommended by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

Chest.

Eileen W, Wechsler ME, Tran TN, Heaney LG, Jones RC, Menzies-Gow AN, Busby J, Jackson DJ, Pfeffer PE, Rhee CK, Cho YS, Canonica GW, Heffler E, Gibson PG, Hew M, Peters M, Harvey ES, Alacqua M, Zangrilli J, Bulathsinhala L, Carter VA, Chaudhry I, Eleangovan N, Hosseini N, Murray RB, Price DB

doi: 10.1016/j.chest.2019.10.053.

Diagnosis and management of asthma - Statement on the 2015 GINA Guidelines

Horak F, Doberer D, Eber E, Horak E, Pohl W, Riedler J, Szépfalusi Z, Wantke F, Zacharasiewicz A, Studnicka M

RECOMMENDED

Asthma

Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma: results from two phase 3, randomised, double-blind, placebo-controlled trials

★ 3 Recommended by Dr Martin Frey, Faculty Member

★ 3 Recommended by Dr Marcus Hesse, Faculty Member

Lancet Respir Med.

Bernstein JA, Virchow JC, Murphy K, Maspero JF, Jacobs J, Adir Y, Humbert M, Castro M, Marsteller DA, McElhattan J, Hickey L, Garin M, Vanlandingham R, Brusselle G

doi: 10.1016/S2213-2600(19)30372-8.

Related content

Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry

Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era

A Charter to Improve Patient Care in Severe Asthma

Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature

Effects of Systemic Corticosteroids on Blood Eosinophil Counts in Asthma: Real-World Data

Differentiation of adult severe asthma from difficult-to-treat asthma - Outcomes of a systematic assessment protocol

Characterization of severe asthma worldwide: data from the International Severe Asthma Registry (ISAR)

Diagnosis and management of asthma - Statement on the 2015 GINA Guidelines

Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma: results from two phase 3, randomised, double-blind, placebo-controlled trials